90 related articles for article (PubMed ID: 36613925)
21. Utilization of lung cancer cell lines for the study of lung cancer stem cells.
Wang Y; Jiang M; Du C; Yu Y; Liu Y; Li M; Luo F
Oncol Lett; 2018 May; 15(5):6791-6798. PubMed ID: 29731860
[TBL] [Abstract][Full Text] [Related]
22. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies.
Liu YC; Yeh CT; Lin KH
Cells; 2020 May; 9(6):. PubMed ID: 32466488
[TBL] [Abstract][Full Text] [Related]
23. Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem Cells.
Pan Z; Zhang M; Zhang F; Pan H; Li Y; Shao Y; Yuan X; Wang J; Chen J
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613925
[TBL] [Abstract][Full Text] [Related]
24. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
Su J; Wu S; Wu H; Li L; Guo T
Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
[TBL] [Abstract][Full Text] [Related]
25. Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma.
Zhou L; He L; Liu CH; Qiu H; Zheng L; Sample KM; Wu Q; Li J; Xie K; Ampuero J; Li Z; Lv D; Liu M; Romero-Gómez M; Hu Y; Tang H
J Exp Clin Cancer Res; 2023 Nov; 42(1):311. PubMed ID: 37993901
[TBL] [Abstract][Full Text] [Related]
26. Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells.
Zhang X; Lou Y; Wang H; Zheng X; Dong Q; Sun J; Han B
Med Oncol; 2015 Apr; 32(4):95. PubMed ID: 25731617
[TBL] [Abstract][Full Text] [Related]
27. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
[No Abstract] [Full Text] [Related]
28. FGF1 and IGF1-conditioned 3D culture system promoted the amplification and cancer stemness of lung cancer cells.
Liu P; Zhang R; Yu W; Ye Y; Cheng Y; Han L; Dong L; Chen Y; Wei X; Yu J
Biomaterials; 2017 Dec; 149():63-76. PubMed ID: 29017078
[TBL] [Abstract][Full Text] [Related]
29. CEBPB is required for NRF2-mediated drug resistance in NRF2-activated non-small cell lung cancer cells.
Okazaki K; Anzawa H; Katsuoka F; Kinoshita K; Sekine H; Motohashi H
J Biochem; 2022 May; 171(5):567-578. PubMed ID: 35137113
[TBL] [Abstract][Full Text] [Related]
30. CD44: A Multifunctional Mediator of Cancer Progression.
Hassn Mesrati M; Syafruddin SE; Mohtar MA; Syahir A
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944493
[TBL] [Abstract][Full Text] [Related]
31. Targeting CD166
El-Ashmawy NE; Salem ML; Abd El-Fattah EE; Khedr EG
Toxicol Appl Pharmacol; 2021 Oct; 429():115699. PubMed ID: 34437932
[TBL] [Abstract][Full Text] [Related]
32. Single-Cell Transcriptomics-Based Study of Transcriptional Regulatory Features in the Mouse Brain Vasculature.
Lin WW; Xu LT; Chen YS; Go K; Sun C; Zhu YJ
Biomed Res Int; 2021; 2021():7643209. PubMed ID: 34337051
[TBL] [Abstract][Full Text] [Related]
33. Integrated analysis of multimodal single-cell data.
Hao Y; Hao S; Andersen-Nissen E; Mauck WM; Zheng S; Butler A; Lee MJ; Wilk AJ; Darby C; Zager M; Hoffman P; Stoeckius M; Papalexi E; Mimitou EP; Jain J; Srivastava A; Stuart T; Fleming LM; Yeung B; Rogers AJ; McElrath JM; Blish CA; Gottardo R; Smibert P; Satija R
Cell; 2021 Jun; 184(13):3573-3587.e29. PubMed ID: 34062119
[TBL] [Abstract][Full Text] [Related]
34. Inference and analysis of cell-cell communication using CellChat.
Jin S; Guerrero-Juarez CF; Zhang L; Chang I; Ramos R; Kuan CH; Myung P; Plikus MV; Nie Q
Nat Commun; 2021 Feb; 12(1):1088. PubMed ID: 33597522
[TBL] [Abstract][Full Text] [Related]
35. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
36. CD44 as a tumor biomarker and therapeutic target.
Xu H; Niu M; Yuan X; Wu K; Liu A
Exp Hematol Oncol; 2020 Dec; 9(1):36. PubMed ID: 33303029
[TBL] [Abstract][Full Text] [Related]
37. The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties.
Liu N; Yang R; Shi Y; Chen L; Liu Y; Wang Z; Liu S; Ouyang L; Wang H; Lai W; Mao C; Wang M; Cheng Y; Liu S; Wang X; Zhou H; Cao Y; Xiao D; Tao Y
Signal Transduct Target Ther; 2020 Sep; 5(1):197. PubMed ID: 32994405
[TBL] [Abstract][Full Text] [Related]
38. A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components.
Nilsson MB; Sun H; Robichaux J; Pfeifer M; McDermott U; Travers J; Diao L; Xi Y; Tong P; Shen L; Hofstad M; Kawakami M; Le X; Liu X; Fan Y; Poteete A; Hu L; Negrao MV; Tran H; Dmitrovsky E; Peng D; Gibbons DL; Wang J; Heymach JV
Sci Transl Med; 2020 Sep; 12(559):. PubMed ID: 32878980
[TBL] [Abstract][Full Text] [Related]
39. Assembly of lung progenitors into developmentally-inspired geometry drives differentiation via cellular tension.
Soleas JP; D'Arcangelo E; Huang L; Karoubi G; Nostro MC; McGuigan AP; Waddell TK
Biomaterials; 2020 Sep; 254():120128. PubMed ID: 32474250
[TBL] [Abstract][Full Text] [Related]
40. Visualizing and interpreting cancer genomics data via the Xena platform.
Goldman MJ; Craft B; Hastie M; Repečka K; McDade F; Kamath A; Banerjee A; Luo Y; Rogers D; Brooks AN; Zhu J; Haussler D
Nat Biotechnol; 2020 Jun; 38(6):675-678. PubMed ID: 32444850
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
